BIO REFERENCE LABORATORIES INC Cashflow Statement

Ask AI

Financial Statements

In millions of USD, except per-share amounts

	FY2014 12 months to Oct 31, 2014	FY2013 12 months to Oct 31, 2013	FY2012 12 months to Oct 31, 2012	FY2011 12 months to Oct 31, 2011
OPERATING ACTIVITIES:
Net Income
Adjustments to Reconcile Net Income to Cash Provided by Operating Activities:
Depreciation and Amortization
Deferred Income Taxes (Benefit) Expense
Stock Based Compensation
(Gain) Loss on Disposal of Fixed Assets
Undistributed Equity Method (Income) Loss
Change in Assets and Liabilities:
(Increase) Decrease in:
Accounts Receivable
Provision for Doubtful Accounts
Inventory
Other Current Assets
Other Assets
Deposits
Increase (Decrease) in:
Accounts Payable and Accrued Liabilities
NET CASH - OPERATING ACTIVITIES
INVESTING ACTIVITIES:
Acquisition of Equipment and Leasehold Improvements
Business Acquisitions Related Costs
NET CASH - INVESTING ACTIVITIES
FINANCING ACTIVITIES:
Payments of Long-Term Debt
Payments of Capital Lease Obligations
Increase (Decrease) in Revolving Line of Credit
Common Stock Repurchase
NET CASH - FINANCING ACTIVITIES
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIODS
CASH AND CASH EQUIVALENTS AT END OF PERIODS
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash paid during the period for:
Interest
Income Taxes
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Equipment with an initial cost
Purchase of new equipment
Capital Leases
Write-off of property
Write-off of Intangible Assets
Stock-based compensation expense
Proceeds from Exercise of Options

Comments